rxstat › Shortages › Naproxen

Naproxen shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Naproxen products are in shortage in Canada (7 of 29 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Aug 21, 2026.
Products affected
7 / 29
In shortage since
Mar 10, 2017
Est. full return
Aug 21, 2026
Reports on file
142
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
APO-NAPROXEN EC TABLETS
250MG · TABLET (ENTERIC-COATED) · APOTEX INC
DIN 02246699 · since May 26, 2026, est. end Aug 21, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-NAPROXEN
250MG · TABLET · TEVA CANADA LIMITED
DIN 00565350 · since Jun 3, 2026, est. end Jun 30, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-NAPROXEN
375MG · TABLET · APOTEX INC
DIN 00600806 · since Mar 17, 2026, est. end Jun 12, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-NAPROXEN EC
500MG · TABLET (ENTERIC-COATED) · APOTEX INC
DIN 02246701 · since Feb 10, 2026, est. end Apr 24, 2026 · Disruption of the manufacture of the drug.
Active shortage
NAPROSYN
500MG · TABLET (ENTERIC-COATED) · ATNAHS PHARMA UK LIMITED
DIN 02162423 · since Sep 21, 2023, est. end Oct 31, 2025 · Other (Please describe in comments)
Active shortage
NAPROSYN
500MG · TABLET (ENTERIC-COATED) · ATNAHS PHARMA UK LIMITED
DIN 02162423 · since Jan 30, 2023, est. end Oct 31, 2025 · Demand increase for the drug.
Active shortage
NAPROSYN
750MG · TABLET (EXTENDED-RELEASE) · ATNAHS PHARMA UK LIMITED
DIN 02162466 · since Oct 2, 2024, est. end Oct 31, 2025 · Other (Please describe in comments)
Active shortage
APO-NAPROXEN SR TABLETS 750MG
750MG · TABLET (EXTENDED-RELEASE) · APOTEX INC
DIN 02177072 · since Mar 10, 2017, no end estimate · Disruption of the manufacture of the drug.
Resolved
TEVA-NAPROXEN
375MG · TABLET · TEVA CANADA LIMITED
DIN 00627097 · ended Jun 24, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-NAPROXEN EC TABLETS
250MG · TABLET (ENTERIC-COATED) · APOTEX INC
DIN 02246699 · ended Apr 23, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-NAPROXEN EC
375MG · TABLET (ENTERIC-COATED) · TEVA CANADA LIMITED
DIN 02243313 · ended Feb 4, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-NAPROXEN EC
250MG · TABLET (ENTERIC-COATED) · TEVA CANADA LIMITED
DIN 02243312 · ended Jan 28, 2026 · Disruption of the manufacture of the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Naproxen is currently affected by 7 active shortage reports filed with Health Canada by APOTEX INC, TEVA CANADA LIMITED, ATNAHS PHARMA UK LIMITED.

The reported causes are: disruption of the manufacture of the drug; other (please describe in comments); demand increase for the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Naproxen is classified under “ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS” (ATC M01AE).

Recent changes

Common questions

When will Naproxen be back in stock in Canada?

The latest manufacturer estimate is Aug 21, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Naproxen in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (antiinflammatory/antirheumatic prod.,non-steroids)

Widespread shortageEsomeprazole Naproxen2 of 3 reported products affected · est. return Nov 24, 2026Widespread shortageTiaprofenic Acid2 of 4 reported products affectedPartial shortageCelecoxib1 of 31 reported products affectedPartial shortageDiclofenac2 of 7 reported products affected · est. return Jul 24, 2026Partial shortageIbuprofen2 of 14 reported products affected · est. return Jul 3, 2026Partial shortageIndomethacin3 of 7 reported products affected · est. return Oct 10, 2026

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.